8-K filing — Axos Financial, Inc. (AX)
Filed: 2026-09-21 AccNo: 0001299709-26-000066 Size: 249 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Benchmark Maintains Buy on Axos Financial, Raises Price Target to $120
Benchmark analyst Andrew Liesch maintains Axos Financial (NYSE:AX) with a Buy and raises the price target from $115 to $120.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
American Express Looks Beyond Cards With New Business Savings Offering
American Express launches a high-yield business savings account offering 2.95% APY with no minimum balance or fees, integrating it with existing business checking and card products. The company plans to add rewards deposit features and AI-powered payroll tools to create a comprehensive business finance platform. The move aims to deepen customer relationships and create an additional funding source through deposit growth.
CPI Card Group (PMTS) Soars 7.8%: Is Further Upside Left in the Stock?
CPI Card Group Inc. (PMTS) shares jumped 7.8% to $24.26 in the last trading session on strong volume, driven by its dominant U.S. market position, long-standing customer relationships, and comprehensive payment card capabilities. The company is expected to report quarterly earnings of $0.84 per share (+78.7% YoY) with revenues of $149.3 million (+8.2% YoY). However, the consensus EPS estimate has remained unchanged over the last 30 days, which may limit further near-term upside without positive earnings revisions.
HLI Flags Rising Stress Among Smaller Private-Credit Borrowers
Houlihan Lokey reports rising private credit stress concentrated among smaller borrowers, with sub-$100M EBITDA companies posting 3% default rates by loan value. The $10M-$20M EBITDA segment shows the most weakness, with 12% of loans trading below 90% of par versus 1% in 2023. Larger borrowers remain healthier, and overall fundamentals remain supportive with median revenue growth of 6.5% and EBITDA growth of 7.4%.